Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy with PBSC in Advanced Breast Cancer (PEGASE03)
NCT00002870Phase 3Completed
- Sponsor
- Unicancer
- Start
- Dec 1994
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide and thiotepa in breast cancer (2 arms), sponsored by Unicancer. Primary endpoint: Disease Free Survival at 5 years. Started Dec 1994; status: completed.
02
Drugs
cyclophosphamidethiotepa
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002870.